After raising near-record amounts in 2018, San Diego startups continued to draw big investments into the new year. In the first quarter of 2019, San Diego companies raised $204 million over 20 deals, down from $358.4 million in the first quarter of 2018, according to a report released on April 9 by PricewaterhouseCoopers and CB Insights.

Nationwide, the amount of funding increased slightly compared to 2018. U.S. companies raised a total of $24.6 billion across 1,279 deals in the first quarter of 2019, compared to $22.8 billion across 1,524 deals at the beginning of 2018.

Though funding in 2019 fell from the explosive funding rounds of late 2018, the U.S. had a record number of unicorns, or private companies valued over $1 billion, with 147 reported in the first quarter. The new year also saw a handful notable companies going public, including Gossamer Bio’s $276 million IPO. The company was valued at $966 million when it went public, making it the third top-valued IPO in the country behind Lyft and Alector Biosciences.

These were the top 20 venture capital investments in the San Diego area, according to the PwC MoneyTree report:

  • Ostendo Technologies - $45 million
  • Wiliot - $30 million
  • Erasca - $22 million
  • Adigica Health - $18.71 million
  • Home Bay - $13.5 million
  • PetDesk - $12 million
  • Zingle - $11 million
  • LeadCrunch - $10.55 million
  • Liquid Instruments - $8.16 million
  • Cardea Bio - $7.8 million
  • Exagen Diagnostics - $6.59 million
  • Biolinq - $4.75 million
  • alwaysAI - $4 million
  • GenomeDx Biosciences - $3.2 million
  • BioIntervene - $3.13 million
  • MixMode - $1.83 million
  • AltheaDx - $1.68 million
  • MedCrypt - $150,000
  • GoMeta – seed round, amount not disclosed
  • JuneShine – seed round, amount not disclosed